Disclose All Medications Let your dental team know if youre taking Ozempic or other GLP-1 medications
The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest
Global GLP-1 innovation is being driven by major pharmaceutical leaders including Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Boehringer Ingelheim International GmbH, Amgen Inc., Biocon, and Teva Pharmaceuticals, who continue to expand treatment options across diabetes, obesity, and metabolic disorders
You can increase the difficulty by holding the repetitions for longer or bringing your hips in line with the height of your knees
The Phase 2 Retatrutide trial included quality of life assessments alongside weight outcomes
Very common side effects feeling sick (nausea) diarrhoea vomiting constipation low blood sugar (if used with certain diabetes medications) Common side effects indigestion stomach pain dizziness allergic reactions low blood pressure hair loss feeling tired bloating burping gas reflux or heartburn injection site reactions an increased level of some pancreatic enzymes as shown in blood tests (such as lipase) increased calcitonin levels Uncommon side effects gallstones fast pulse injection site pain gall bladder infection (cholecystitis) inflammation of the pancreas an increased level of some pancreatic enzymes as shown in blood tests (such as amylase) increased calcitonin levels in blood change in sense of taste skin sensation changes delay in stomach emptying For a full list of the side effects see the Patient Information Leaflet